Published in

American Association for the Advancement of Science, Science, 6567(374), 2021

DOI: 10.1126/science.abj3624

Links

Tools

Export citation

Search in Google Scholar

A prenylated dsRNA sensor protects against severe COVID-19

Journal article published in 2021 by Arthur Wickenhagen ORCID, Jeffrey Y. Lee, Elena Sugrue, Spyros Lytras, Srikeerthana Kuchi, Matthew L. Turnbull, Marko Noerenberg, Colin Loney, Rute M. Pinto, J. Kenneth Baillie, Louisa Iselin, Natasha Palmalux, Vanessa Herder, Douglas G. Stewart, Luiz Carlos de Lima Ferreira and other authors.
This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO

Abstract

The bat connection The heterogeneity of COVID-19 makes it challenging to predict the course of infection in an individual. Upon virus infection, interferons (IFNs) generate the initial signals for cellular defenses. Knowing that defects in IFN signaling are associated with more severe COVID-19, Wickenhagen et al . used IFN-stimulated gene expression screening on human lung cells from which they identified a gene for 2′-5′-oligoadenylate synthetase 1 (OAS1) (see the Perspective by Schoggins). OAS1 stimulates RNase L to inhibit the virus with a surprising degree of specificity, targeting the membranous organelles in which it replicates. In most mammals, OAS1 is attached to membranes by a prenyl group. However, billions of humans do not have the prenylated OAS1 haplotype, including many experiencing severe COVID-19. The same is true for horseshoe bats, prolific sources of betacoronaviruses, because of an ancient retrotransposition event. —CA